Galloway, J. B., Hyrich, K. L., Mercer, L. K., Dixon, W. G., Fu, B., Ustianowski, A. P., . . . Symmons, D. P. M. (2011). Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: Updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Oxford University Press.

Galloway, James B., Kimme L. Hyrich, Louise K. Mercer, William G. Dixon, Bo Fu, Andrew P. Ustianowski, Kath D. Watson, Mark Lunt, and Deborah P. M. Symmons. Anti-TNF Therapy Is Associated With an Increased Risk of Serious Infections in Patients With Rheumatoid Arthritis Especially in the First 6 Months of Treatment: Updated Results From the British Society for Rheumatology Biologics Register With Special Emphasis On Risks in the Elderly. Oxford University Press, 2011.

Galloway, James B., et al. Anti-TNF Therapy Is Associated With an Increased Risk of Serious Infections in Patients With Rheumatoid Arthritis Especially in the First 6 Months of Treatment: Updated Results From the British Society for Rheumatology Biologics Register With Special Emphasis On Risks in the Elderly. Oxford University Press, 2011.